NASDAQ:SRDX
SurModics Stock News
$32.16
-0.160 (-0.495%)
At Close: May 10, 2024
Surmodics (SRDX) Q1 Earnings Beat Estimates, Revenues Miss
12:27pm, Wednesday, 10'th Feb 2021
Surmodics (SRDX) records higher revenues in its In Vitro Diagnostics core unit in the fiscal first quarter.
Surmodics, Inc. (SRDX) CEO Gary Maharaj on Q1 2021 Results - Earnings Call Transcript
01:07pm, Tuesday, 09'th Feb 2021
Surmodics, Inc. (SRDX) CEO Gary Maharaj on Q1 2021 Results - Earnings Call Transcript
SurModics (SRDX) Beats Q1 Earnings Estimates
09:51am, Tuesday, 09'th Feb 2021
SurModics (SRDX) delivered earnings and revenue surprises of 133.33% and -3.81%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?
Recap: Surmodics Q1 Earnings
07:44am, Tuesday, 09'th Feb 2021
Shares of Surmodics (NASDAQ:SRDX) rose 2.1% in pre-market trading after the company reported Q1 results. Quarterly Results Earnings per share fell 60.00% over the past year to $0.02, which beat the es
Analysts Estimate SurModics (SRDX) to Report a Decline in Earnings: What to Look Out for
01:38pm, Tuesday, 02'nd Feb 2021
SurModics (SRDX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
PAHC vs. SRDX: Which Stock Should Value Investors Buy Now?
12:48pm, Wednesday, 20'th Jan 2021
PAHC vs. SRDX: Which Stock Is the Better Value Option?
Surmodics, Inc.'s (SRDX) CEO Gary Maharaj on Q4 2020 Results - Earnings Call Transcript
11:50pm, Wednesday, 04'th Nov 2020
Surmodics, Inc.'s (SRDX) CEO Gary Maharaj on Q4 2020 Results - Earnings Call Transcript
Surmodics Is One For The Future, With High Conversion Potential From The Pipeline
07:17pm, Monday, 02'nd Nov 2020
Surmodics is in the early stages of an extended growth period in our view, with high conversion potential from their pipeline. The company has key differentiators within its medical devices and IVD se
